Total Funding
39
54
Total FundingPost-IPO Debt raised
Growth Score
-2 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
208523
Argent BioPharma is a specialized biopharmaceutical firm that develops and markets novel medications.
Brett Mitchell: Executive ChairmanPast Role: Salt Lake Potash, Director- Nadya Lisovoder: Chief Medical Officer
About the Company
Argent BioPharma is a specialized biopharmaceutical firm that develops and markets novel medications.Argent BioPharma intends to be a premier biopharmaceutical firm known worldwide for developing new medicines that address unmet medical needs, particularly in the central nervous system (CNS) and immune-related illnesses.
